Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

30 results about "Cholane" patented technology

Cholane is a triterpene which can exist as either of two stereoisomers, 5α-cholane and 5β-cholane. Its name is derived from the Greek work for bile (χολή, chole) in reference to its original discovery from the bile of the American bullfrog (Rana catesbeiana). The compound itself has no known uses; however, various functionalized analogues are produced by plants and animals, typically in the form of sterols, steroids and bile acids (e.g. cholic acid).

Limit detection method of bear gall powder extract in phlegm-heat clearing injection and fingerprint spectrum thereof

The invention relates to a limit detection method for a bear gall powder extract in a phlegm-heat clearing injection. The bear gall powder extract comprises ursodeoxycholic acid, chenodeoxycholic acid, 3 [alpha]-hydroxyl-7-oxo-5[beta]-cholanic acid and 7 [alpha]-hydroxyl-3-oxo-5[beta]-cholanic acid. The limit detection method is an HPLC-DAD method and comprises the following steps: S1, preparing areference substance solution; S2, preparing a test solution; and S3, performing limit detection. The invention also relates to a fingerprint spectrum obtained by adopting the limit detection method,the fingerprint spectrum has four characteristic peaks in total, and each peak takes an ursodeoxycholic acid peak as a reference peak. According to the limit detection method disclosed by the invention, limit detection is carried out on the bear gall powder extract by calculating the peak area of a test sample and the peak area of a reference substance through adoption of an external standard method; by calculating the similarity between the fingerprint spectrum of the test sample and the reference fingerprint spectrum, the product quality is accurately, efficiently and comprehensively monitored, and meanwhile, the authenticity of the product is identified.
Owner:SHANGHAI KAIBAO PHARMA +1

Method for extracting (20R)-22E-24-ethyl cholane-4,22-diene-3-ketone from stems and leaves of Coix lacryma-jobi

The invention discloses a method for extracting (20R)-22E-24-ethyl cholane-4,22-diene-3-ketone from stems and leaves of Coix lacryma-jobi. The method comprises the following steps: dried stems and leaves of Coix lacryma-jobi are crushed, ethanol is added and heated, reflux extraction is carried out, and an extracting solution is condensed in order to obtain an extract A; water is added into the extract A and the extract A is dispersed, petroleum ether is used for extraction, and petroleum ether is partially condensed in order to obtain an extract B; silica gel column chromatography is carried out for the extract B firstly, petroleum ether-ethyl acetate gradient elution is carried out, separated and purified components are collected, chromatography is carried out, pure dichloromethane is used for elution, separated and purified components are separated and purified by preparation type high performance liquid chromatography, a tR=31 min component is collected, condensation and crystallization are carried out, and the product is obtained. (20R)-22E-24-ethyl cholane-4,22-diene-3-ketone is extracted from waste stems and leaves of Coix lachrymal-jobi, environmental pollution is reduced, utilization rate of stems and leaves of Coix lacryma-jobi is improved, an industry chain of Coix lacryma-jobi is prolonged, income of Coix lacryma-jobi industry is increased, and the method has good economic benefits and ecological benefits.
Owner:右江民族医学院

Long-acting Rasagiline prodrug as well as preparation method and application thereof

The invention relates to a long-acting Rasagiline prodrug as well as a preparation method and application thereof. The structure of the long-acting Rasagiline prodrug is as shown in formula I: (shownin the description), wherein T is selected from (shown in the description) or none; R1 and R2 are respectively independently selected from hydrogen, deuterium and methyl; W is selected from (CH2)N ornone, and n is selected from an integer of 1 to 15; X is selected from (CH2)m or none, and m is selected from an integer of 1 to 10; Y is selected from -C(=O)NH-, -NHC(=O) or none; and R3 is selectedfrom substituted or unsubstituted alkyl of C1 to C30, substituted or unsubstituted C2 to C3 alkenyl, substituted or unsubstituted C2 to C30 alkynyl, substituted or unsubstituted C3 to C30 naphthenic base, cholanic aliphatic chain, -R<3a>-C(=O)O-R<3b>, -R<3a>-OC(=O)-R<3b>, -R<3a>-C(=O)NH-R<3b>, -R<3a>-NHC(=O)-R<3b>, or -R<3a>-S(=O)1-2O-R<3b> and -R<3a>-OS(=O)1-2-R<3b>. The Rasagiline prodrug of theinvention is high in melting point, low in solubility, capable of forming a drug library by virtue of injection administration in a body, capable of increasing the release time of the drug in the body, and capable of playing the lasting-acting treatment.
Owner:GUANGZHOU HENOVCOM BIOSCI CO LTD

Method for determining content of related components of four bear gall powder in cooling-based phlegm eliminating injection

The invention relates to the field of chemistry, in particular to a method for determining the content of related components of four bear gall powder in cooling-based phlegm eliminating injection. Themethod comprises the following steps: S1, preparing a reference solution; S2, preparing a test solution; S3, performing detecting by using a high performance liquid chromatograph-mass spectrometer; S4, carrying out qualitative detection; and S5, performing quantitative detection: according to the method, under the condition set by a high performance liquid chromatograph-mass spectrometer, respectively carrying out determination, repeating the process for 6 times, determining the peak area of the corresponding concentration, and carrying out linear regression to obtain a regression equation soas to obtain a correlation coefficient and a linear range and determine the contents of the four bear gall powder related components in the cooling-based phlegm eliminating injection. The method canbe used for qualitatively analyzing ursodeoxycholic acid, 3alpha- hydroxyl-7oxo-5beta-cholanic acid, chenodeoxycholic acid and 7alpha- hydroxyl-3-oxo-5beta-cholanic acid of the cooling-based phlegm eliminating injection and the bear gall powder extract, and is simple and convenient to operate, stable in result, good in reproducibility and high in precision.
Owner:SHANGHAI KAIBAO PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products